BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28068865)

  • 1. Testing for homocysteine in clinical practice.
    Nichols J
    Nutr Health; 2017 Mar; 23(1):13-15. PubMed ID: 28068865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The methionine-homocysteine cycle and its effects on cognitive diseases.
    Miller AL
    Altern Med Rev; 2003 Feb; 8(1):7-19. PubMed ID: 12611557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperhomocysteinemia in dementia.
    Leblhuber F; Walli J; Artner-Dworzak E; Vrecko K; Widner B; Reibnegger G; Fuchs D
    J Neural Transm (Vienna); 2000; 107(12):1469-74. PubMed ID: 11458999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Updating the relationship between hyperhomocysteinemia lowering therapy and cardiovascular events.
    Cheng X
    Cardiovasc Ther; 2013 Aug; 31(4):e19-26. PubMed ID: 23082962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M;
    Clin Chem Lab Med; 2003 Nov; 41(11):1392-403. PubMed ID: 14656016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of homocysteine as a cardiovascular risk factor in clinical practice.
    Clarke R; Stansbie D
    Ann Clin Biochem; 2001 Nov; 38(Pt 6):624-32. PubMed ID: 11732645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial.
    Aisen PS; Schneider LS; Sano M; Diaz-Arrastia R; van Dyck CH; Weiner MF; Bottiglieri T; Jin S; Stokes KT; Thomas RG; Thal LJ;
    JAMA; 2008 Oct; 300(15):1774-83. PubMed ID: 18854539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homocysteine and cognitive function.
    Troen A; Rosenberg I
    Semin Vasc Med; 2005 May; 5(2):209-14. PubMed ID: 16047273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Causes of hyperhomocysteinemia and its pathological significance.
    Kim J; Kim H; Roh H; Kwon Y
    Arch Pharm Res; 2018 Apr; 41(4):372-383. PubMed ID: 29552692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of homocysteine-lowering B-vitamins in the primary prevention of cardiovascular disease.
    Debreceni B; Debreceni L
    Cardiovasc Ther; 2014 Jun; 32(3):130-8. PubMed ID: 24571382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The controversial role of B-vitamins in cardiovascular risk: An update.
    Ntaios G; Savopoulos C; Grekas D; Hatzitolios A
    Arch Cardiovasc Dis; 2009 Dec; 102(12):847-54. PubMed ID: 19963194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamins and minerals 4: overview of folate and the B vitamins.
    Thompson J
    Community Pract; 2006 Jun; 79(6):197-8. PubMed ID: 16780289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Homocysteine and Alzheimer's disease].
    Qin Y; Qi JS; Qiao JT
    Sheng Li Ke Xue Jin Zhan; 2004 Jan; 35(1):66-9. PubMed ID: 15127604
    [No Abstract]   [Full Text] [Related]  

  • 15. Homocysteine as a biomarker for cognitive dysfunction in the elderly.
    Schulz RJ
    Curr Opin Clin Nutr Metab Care; 2007 Nov; 10(6):718-23. PubMed ID: 18089953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Disturbances of homocysteine metabolism as a risk factor of cardiovascular diseases development: effect on prognosis and possibilities of correction with drugs].
    Shakhmatova OO; Komarov AL; Panchenko EP
    Kardiologiia; 2010; 50(1):42-50. PubMed ID: 20144157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The clinical studies of hyperhomocysteinemia and Alzheimer's disease].
    Li YL; Hou Y; Niu C; Yu LX; Cheng YY; Hong Y
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2013 Mar; 29(2):116-8, 127. PubMed ID: 23833960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hyperhomocysteinemia in pediatric age and nutritional aspects of folates: an early cardiovascular risk factor].
    Caramia G; Belardinelli R
    Monaldi Arch Chest Dis; 2006 Dec; 66(4):275-85. PubMed ID: 17312847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic complication of diabetes and homocysteine].
    Idzior-Waluś B; Cieślik G
    Przegl Lek; 2000; 57(12):732-5. PubMed ID: 11398598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Public health control of hyperhomocysteinemia and its consequences].
    Czeizel E; Kalina A
    Orv Hetil; 2003 Oct; 144(40):1981-9. PubMed ID: 14626640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.